As the world rushes to put contact tracing and illness-tracking tools in place to enable effective response to the coronavirus pandemic, privacy experts are raising concerns about exactly how this technology will be built and governed.

The Corporations and Society Initiative at Stanford Graduate School of Business and the Center for Internet and Society at Stanford Law School co-sponsored a panel discussion on the use and governance of surveillance technology during (and after) the coronavirus pandemic. Our panelists shared their thoughts on how to align private and public sector interests to benefit society and support public health efforts, while also preserving privacy and civil rights.

Panelists:
Inder Singh is the founder and CEO of Kinsa, a connected medical device company on a mission to curb the spread of infectious illness through early detection and early response.

Doug Fridsma, MD, PhD, is the former president and CEO of AMIA, and former chief science officer for the Office of the National Coordinator for Health Information Technology (ONC).

Jon Callas is a cryptographer, software engineer, UX designer, entrepreneur, and senior technology fellow at the ACLU.

Gretchen Greene is a senior advisor at the Hastings Center and an international AI policy advisor, as well as a Yale-trained lawyer, computer vision scientist, autonomous vehicle engineer, and former U.S. national lab mathematician.

Albert Gidari (moderator) is the consulting director of privacy at the Stanford Center for Internet and Society.